Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
2.420
+0.065 (2.76%)
At close: Sep 3, 2026, 4:00 PM EDT
2.380
-0.040 (-1.65%)
After-hours: Sep 3, 2026, 7:10 PM EDT
Lipocine Market Cap
Lipocine has a market cap or net worth of $19.95 million as of September 3, 2026. Its market cap has increased by 27.08% in one year.
Market Cap
19.95M
Enterprise Value
-3.06M
1-Year Change
27.08%
Ranking
Category
Stock Price
$2.42
ChartMarket Cap Chart
Since March 21, 2014, Lipocine's market cap has decreased from $82.30M to $19.95M, a decrease of -75.76%. That is a compound annual growth rate of -10.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 20.00M | -55.16% |
| Dec 31, 2025 | 44.60M | 70.88% |
| Dec 31, 2024 | 26.10M | 76.35% |
| Dec 29, 2023 | 14.80M | -57.95% |
| Dec 30, 2022 | 35.20M | -59.77% |
| Dec 31, 2021 | 87.50M | -2.02% |
| Dec 31, 2020 | 89.30M | 811.22% |
| Dec 31, 2019 | 9.80M | -64.87% |
| Dec 31, 2018 | 27.90M | -61.73% |
| Dec 29, 2017 | 72.90M | 8.48% |
| Dec 30, 2016 | 67.20M | -71.53% |
| Dec 31, 2015 | 236.00M | 250.67% |
| Dec 31, 2014 | 67.30M | -18.23% |
| Mar 21, 2014 | 82.30M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Akari Therapeutics, | 20.31M |
| Dyadic International | 20.23M |
| Niki BioSolutions | 20.16M |
| Chemomab Therapeutics | 19.71M |
| Pasithea Therapeutics | 19.18M |
| NewcelX | 18.92M |
| Lexaria Bioscience | 18.64M |
| Tempest Therapeutics | 17.42M |